title: Deep brain stimulation for the treatment of addiction: basic and clinical studies and potential mechanisms of action.
abstract: BACKGROUND
  Deep brain stimulation (DBS) has achieved substantial success as a treatment for movement disorders such as Parkinson's disease. The therapeutic efficacy and relative lack of serious side effects resulted in the expansion of DBS into the treatment of many other diseases, including obsessive-compulsive disorder, Tourette's, and depression, among others. More recently, a limited number of basic and clinical studies indicated that DBS may also be useful in the treatment of various addictions.
  
  
  OBJECTIVE
  Here, we briefly summarize the history of DBS and review the basic and clinical studies focused on DBS and addiction. We also examine the potential mechanisms that may underlie the effects of DBS.
  
  
  CONCLUSIONS
  The available data indicate that DBS is a promising therapeutic modality for the treatment of addiction. Thus far, the nucleus accumbens and subthalamic nucleus are the most promising sites for DBS, reversing aspects of addiction. The mechanisms underlying DBS are complex and likely vary from region to region. Emerging evidence indicates that DBS of the nucleus accumbens produces its effects, at least in part, by antidromic activation of cortico-accumbal afferents that stimulate inhibitory medial prefrontal cortex interneurons via recurrent collaterals.
authors.affiliation: Center for Neurobiology and Behavior, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA, rcpierce@mail.med.upenn.edu.
authors.forename: R Christopher
authors.initials: RC
authors.lastname: Pierce
authors.forename: Fair M
authors.initials: FM
authors.lastname: Vassoler
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D046690:Deep Brain Stimulation / Q000379:methods*; D058999:Drug-Seeking Behavior / Q000502:physiology; D006801:Humans; D009714:Nucleus Accumbens / Q000378:metabolism / Q000503:physiopathology*; D019966:Substance-Related Disorders / Q000378:metabolism / Q000523:psychology* / Q000628:therapy*; D020531:Subthalamic Nucleus / Q000378:metabolism / Q000503:physiopathology*; D016896:Treatment Outcome
references.citation: Neurosci Biobehav Rev. 2008;32(3):388-407
references.pmid: 17706780
references.citation: Lancet. 1999 Feb 27;353(9154):724
references.pmid: 10073521
references.citation: J Neuropsychiatry Clin Neurosci. 1997 Summer;9(3):354-81
references.pmid: 9276840
references.citation: Neuron. 2013 Feb 6;77(3):406-24
references.pmid: 23395370
references.citation: J Neurosurg. 1992 Jan;76(1):53-61
references.pmid: 1727169
references.citation: Mol Psychiatry. 2012 Jun;17(6):572-83
references.pmid: 21931318
references.citation: Neurosci Lett. 1996 Aug 30;215(1):17-20
references.pmid: 8880743
references.citation: Exp Brain Res. 1998 Feb;118(4):489-500
references.pmid: 9504844
references.citation: Neurology. 2000;55(12 Suppl 6):S13-6
references.pmid: 11188968
references.citation: J Neurosci. 2007 Nov 14;27(46):12601-10
references.pmid: 18003839
references.citation: Cogn Behav Neurol. 2008 Sep;21(3):187-9
references.pmid: 18797262
references.citation: Acta Psychiatr Scand. 1960;35(3):358-77
references.pmid: 13835931
references.citation: Addict Biol. 2008 Mar;13(1):40-6
references.pmid: 18269379
references.citation: Neuroscience. 1999;93(4):1359-67
references.pmid: 10501460
references.citation: Brain Stimul. 2013 May;6(3):274-85
references.pmid: 22981894
references.citation: Addiction. 2011 Feb;106(2):235-7
references.pmid: 21208310
references.citation: Lancet. 1999 Oct 30;354(9189):1526
references.pmid: 10551504
references.citation: Pharmacol Biochem Behav. 2009 May;92(3):474-9
references.pmid: 19463262
references.citation: Adv Neurol. 2001;86:405-12
references.pmid: 11554003
references.citation: Science. 1990 Sep 21;249(4975):1436-8
references.pmid: 2402638
references.citation: BMJ Case Rep. 2009;2009:
references.pmid: 21686755
references.citation: Biol Psychiatry. 2012 Apr 15;71(8):e35-7
references.pmid: 22281120
references.citation: Surg Neurol. 1975 Jul;4(1):93-5
references.pmid: 1080908
references.citation: Neurosurgery. 2008 Feb;62 Suppl 2:863-74
references.pmid: 18596421
references.citation: Neuroscience. 2002;113(1):137-43
references.pmid: 12123692
references.citation: Proc Natl Acad Sci U S A. 2010 Jan 19;107(3):1196-200
references.pmid: 20080543
references.citation: Neurosci Biobehav Rev. 2006;30(2):215-38
references.pmid: 16099045
references.citation: Neuron. 2005 Mar 3;45(5):647-50
references.pmid: 15748840
references.citation: Science. 2009 Apr 17;324(5925):354-9
references.pmid: 19299587
references.citation: J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):868-74
references.pmid: 23447648
references.citation: Biol Psychiatry. 2011 Jun 1;69(11):e41-2
references.pmid: 21489407
references.citation: J Neurol Neurosurg Psychiatry. 2007 Oct;78(10):1152-3
references.pmid: 17878197
references.citation: Clin Neurophysiol. 2004 Jun;115(6):1239-48
references.pmid: 15134690
references.citation: Neuron. 2005 Mar 3;45(5):651-60
references.pmid: 15748841
references.citation: J Neurosci. 2009 Apr 22;29(16):5354-63
references.pmid: 19386932
references.citation: Mov Disord. 2005 Aug;20(8):1052-5
references.pmid: 15858803
references.citation: J Neurol Neurosurg Psychiatry. 2006 Jul;77(7):868-72
references.pmid: 16574733
references.citation: Mov Disord. 2012 Jun;27(7):930-3
references.pmid: 22674402
references.citation: J Ment Sci. 1952 Jul;98(412):421-6
references.pmid: 14938885
references.citation: N Engl J Med. 1998 Oct 15;339(16):1105-11
references.pmid: 9770557
references.citation: Neurosurgery. 2010 Jan;66(1):E218; discussion E218
references.pmid: 20023526
references.citation: Appl Neurophysiol. 1987;50(1-6):344-6
references.pmid: 3329873
references.citation: Ann N Y Acad Sci. 2013 Apr;1282:119-28
references.pmid: 23227826
references.citation: World J Biol Psychiatry. 2011 Oct;12(7):516-27
references.pmid: 21736514
references.citation: Mov Disord. 2002;17 Suppl 3:S69-72
references.pmid: 11948757
references.citation: Lancet Neurol. 2003 Oct;2(10):595-604
references.pmid: 14505581
references.citation: J Neurosci. 2008 Aug 27;28(35):8735-9
references.pmid: 18753374
references.citation: J Clin Neurosci. 2009 Sep;16(9):1148-52
references.pmid: 19553125
references.citation: Brain Res. 2008 Jun 18;1215:173-82
references.pmid: 18486119
references.citation: Confin Neurol. 1952;12(5-6):315-9
references.pmid: 13010010
references.citation: Brain. 2012 May;135(Pt 5):1463-77
references.pmid: 22508959
references.citation: Eur J Neurosci. 2000 Nov;12(11):4141-6
references.pmid: 11069610
references.citation: Ann N Y Acad Sci. 2010 Feb;1187:35-75
references.pmid: 20201846
references.citation: Eur J Neurosci. 2003 May;17(10):2180-6
references.pmid: 12786985
references.citation: Neurosci Biobehav Rev. 2000 Jan;24(1):85-105
references.pmid: 10654664
references.citation: Lancet. 1995 Jan 14;345(8942):91-5
references.pmid: 7815888
references.citation: Neurosurg Focus. 2010 Aug;29(2):E12
references.pmid: 20672914
references.citation: Nat Neurosci. 2005 Apr;8(4):484-9
references.pmid: 15793577